Gilead: Trodelvy + Keytruda Boosts Survival
Trodelvy + Keytruda improves progression-free survival in untreated PD-L1+ metastatic triple-negative breast cancer.
Read full article »
Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs for a wide range of diseases.
Read more